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Background: Newly synthesized HIV-1 particles assemble at the plasma membrane of infected cells, before being
released as free virions or being transferred through direct cell-to-cell contacts to neighboring cells. Localization of
HIV-1 Gag precursor at the cell membrane is necessary and sufficient to trigger viral assembly, whereas the GagPol
precursor is additionally required to generate a fully matured virion. HIV-1 Nef is an accessory protein that optimizes
viral replication through partly defined mechanisms. Whether Nef modulates Gag and/or GagPol localization and
assembly at the membrane and facilitates viral cell-to-cell transfer has not been extensively characterized so far.
Results: We report that Nef increases the total amount of Gag proteins present in infected cells, and promotes Gag
localization at the cell membrane. Moreover, the processing of p55 into p24 is improved in the presence of Nef. We
also examined the effect of Nef during HIV-1 cell-to-cell transfer. We show that without Nef, viral transfer through
direct contacts between infected cells and target cells is impaired. With a nef-deleted virus, the number of HIV-1
positive target cells after a short 2h co-culture is reduced, and viral material transferred to uninfected cells is less
matured. At later time points, this defect is associated with a reduction in the productive infection of new target
cells.
Conclusions: Our results highlight a previously unappreciated role of Nef during the viral replication cycle. Nef
promotes HIV-1 Gag membrane localization and processing, and facilitates viral cell-to-cell transfer.Background
Human Immunodeficiency virus type-1 (HIV-1) contains
three structural proteins: Pr55Gag (also termed Gag or
p55), Pr160GagPol (GagPol) and the envelope (Env) pro-
tein. The p55 precursor is the building block of HIV-1 as-
sembly and is necessary and sufficient for the production
of viral like particles (VLPs). Gag is organized into four
major domains: matrix (MA or p17), capsid (CA or p24),
nucleocapsid (NC) and p6. During translation of the Gag
mRNA, a ribosomal frame shift occurs at an efficiency of
5-10% and generates the 160kDa precursor GagPol fusion
protein. The Pol region contains virus specific enzymes,
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reproduction in any medium, provided the or(IN). Following Gag and GagPol translation, both proteins
are relocated to the cell membranes and co-assemble into
virus particles at a ratio of 10–20:1 [1]. Gag directs parti-
cles assembly, whereas GagPol is incorporated into viral
particles following its interaction with Gag [2-4]. GagPol
incorporation is crucial for infectivity since virion matur-
ation requires the PR activity that is auto-catalytically acti-
vated during or immediately after viral budding. Of note
we refer throughout the text to “Gag proteins” to indicate
all Gag species (immature and mature) present in infected
cells. Some processed forms of Gag can be found in the
cytoplasm of infected cells but these do not seem to con-
tribute to virus particle formation [5]. Additionally, pre-
mature Gag processing reduces the infectivity of the
virions [6,7]. The site of viral assembly varies depending
on the type of the producer cell (for recent reviews see
[8,9] and [10]). In some cell lines (293T and HeLa), as well
as in primary CD4+ T cells, assembly takes place mostly atLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ding of HIV-1 at the PM leads to both cell-free virus
spreading and viral cell-to-cell transmission to neighboring
cells [13,14]. In macrophages, virus assembly and accumu-
lation have been visualized in intracellular compartments
that may be connected to the extracellular milieu [15,16].
In the cytoplasm, Gag is mostly found as monomers and
dimers whereas higher ordered multimers are detected
once Gag has reached the membranes [17]. The binding
and accumulation of Gag to the membranes is a coopera-
tive process regulated in part by the total amount of Gag in
infected cells [18].
Early studies have demonstrated the importance of Nef
for efficient viral replication and pathogenesis in vivo: nef-
deleted SIVmac239 displays attenuated viral replication and
pathogenicity in rhesus macaques [19]. Mutations and dele-
tions of HIV-1 nef have been found in virus isolates from
several HIV-1 long-term non-progressors [20-22]. In vitro,
Nef is a multi-functional protein responsible for: (1) down-
regulation of cell surface molecules such as CD4, major
histocompatibility complex class I and class II, CD28, and
CD3, (2) enhancement of virion infectivity and stimulation
of viral replication, and (3) modulation of T cell activation
state (for recent reviews see [23] and [24]).
Viral particles can infect target cells both as cell-free vi-
rions and through cell-to-cell contacts. This latter mode of
infection may have an important role in vivo, due to the
tight packing of immune cells in lymph nodes [25], which
represent a major site of viral replication. Cell-to-cell HIV-1
spread is up to 1000 times more efficient than infection via
cell-free virus [26,27], and leads to simultaneous transmis-
sion of HIV-1 to multiple target cells [28]. The high multi-
plicity of infection associated with cell-to-cell transmission
may also facilitate escape from host innate antiviral pressure,
from some neutralizing antibodies, and from antiretroviral
treatment [29-32] [33,34]. In vitro, various modes of HIV-1
cell-to-cell spread have been described, including transfer
through virological synapses (VS) and long distance interac-
tions mediated by filopodia and nanotubes [35-37]. HIV-1
cell-to-cell spread can be divided into different steps. The
first is the formation of a conjugate between one infected
donor cell and one or more uninfected targets. This may
lead to the second step, the formation of the VS [38]. VS are
defined by the polarization of cellular and viral proteins at
the site of contact between donor and target cells. HIV-1
Env proteins expressed on the surface of infected donor cells
and CD4 and co-receptors on the targets stabilize cell-cell
contacts, which are strengthened by cellular adhesion mole-
cules [26,39], facilitating the transfer of newly formed viral
particles to targets. Finally, viral fusion, at the cell surface or
following endocytosis [40,41], will lead to productive infec-
tion, that we term here HIV-1 transmission.
Here, we describe the impact of Nef on the expression,
localization, and maturation of Gag proteins in infectedcells, as well as its effect on viral release and cell-to-cell
transfer.
Results
Nef increases the amount of HIV-1 Gag proteins in
HeLa cells
We first asked if Nef affects the global amount of Gag
proteins (immature and/or mature) in infected cells. We
infected HeLa cells with wild-type (WT) or nef-deleted
(ΔNef) viruses pseudotyped with VSV-G. Two days later,
we analyzed Gag proteins expression by flow cytometry
using the KC57 antibody that recognizes an epitope
contained in the p24 domain of p55. As shown in Figure 1a,
even though the fraction of Gag (KC57) positive cells was
similar with both viruses, the mean fluorescence intensity
(MFI) of the KC57 staining in ΔNef-infected cells was sig-
nificantly reduced. We asked if this decrease corresponded
to a global reduction in the amount of Gag proteins and/or
to a reduced processing of Gag. To assess the relative
amounts of p55 and p24 in WT or ΔNef infected cells we
performed a western blot analysis using the monoclonal
anti HIV-1 p24 25A antibody (Additional file 1b,c). There
was no difference in the amount of p55 in the absence of
Nef, whereas p24 levels were reduced by about 3 fold. We
also performed flow cytometry analysis with another anti-
HIV-1 p24 monoclonal antibody 183-H12-5C [42], here-
after indicated as 183. The MFI of 183 signal was signifi-
cantly reduced in ΔNef infected cells (Additional file 1d,e),
similarly to the results obtained with KC57. We then mea-
sured the global amount of Gag proteins in infected cells
(cell-associated) and released in the supernatants using an
ELISA assay. We used the 183 antibody, that detects ma-
ture p24 proteins, and not the p55 precursor by ELISA
(Additional file 1f,g). In agreement with flow cytometry, we
observed a significant reduction of cell-associated Gag pro-
teins in the absence of Nef (Figure 1b). WT viruses were se-
creted in the supernatant at 3 ng /ml of p24 per infected
cell, whereas in the absence of Nef this secretion was sig-
nificantly lower (Figure 1b). We calculated the efficiency of
viral release by dividing the amounts of p24 in the superna-
tants by those in the total culture (supernatant plus cell-
associated) [43,44]. We did not observe differences between
WT- and ΔNef-infected cells (Figure 1c), indicating that
Nef increases the overall amount of p24 in infected cells
without affecting viral release, defined as the ratio of extra-
cellular to total (extracellular+cell-associated) p24.
We confirmed the effect of Nef on the levels of Gag pro-
teins using the HIV-1 GagGFP molecular clone, in which
the GFP protein is inserted in frame at the C-terminal of
the p17-MA [45]. Following GFP levels by flow cytometry
allows simultaneous detection of both immature and
processed forms of Gag [45]. We infected HeLa cells with
VSV-G-pseudotyped WT-GagGFP or ΔNef-GagGFP vi-
ruses. The MFI of Gag-GFP proteins was significantly
Figure 1 Nef increases the amount of Gag proteins in HeLa cells. HeLa cells were infected with VSV-G-pseudotyped wild type (WT) or
nef-deleted (ΔNef) viruses. At day 2 post-infection cells were stained with the anti HIV-1 p24 KC57 antibody and the percentage of KC57 positive cells
and their relative mean fluorescence intensity (MFI) were analyzed by flow cytometry. (a) Representative dot plots of infected HeLa cells (left panels).
Percentage of KC57 positive cells is indicated in the top right corner of the gated population. MFI for the gated population is also indicated. A
compilation of 10 independent experiments (Mean+SEM) of the percentage of KC57 positive cells and the Gag (KC57) MFI are shown (right panels).
(b). Levels of HIV-1 p24 (in ng/ml) in the supernatants and cell lysates derived from cells described in (a) and measured by ELISA using the anti HIV-1
p24 183-H12-5C antibody. (c) The efficiency of viral release was calculated as the ratio between the levels of HIV-1 p24 in the supernatants and the
total antigen HIV-1 p24 (supernatant + cell associated). Mean+SEM is shown. (d). HeLa cells were infected with VSV-G-pseudotyped WT- or ΔNef
viruses in which the green fluorescent protein (GFP) was inserted in frame with Gag-p17 (Gag-GFP). Cells were harvested at day 2 post-infection and
analyzed by flow cytometry. Of note GFP signal does not distinguish between the mature and immature forms of Gag-GFP. The Gag-GFP MFI was
measured on gated Gag-GFP positive HeLa cells. Representative dot plot analysis (left panel) in which the percentage of Gag-GFP positive cells is
indicated in the top right corner of the gated population together with the MFI. Mean+SEM of 3 independent experiments of Gag-GFP MFI (right
panel). *p<0.05; **p<0.01 (Mann Whitney test).
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various antibodies (KC57, 183 and 25A), and different tech-
niques (flow cytometry, ELISA and western blot) as well as
an HIV-1 Gag-GFP molecular clone, we showed that there
is a significant reduction of the total amount of HIV-1 Gag
proteins, and of the levels of mature p24 in ΔNef-infected
cells.
Nef increases HIV-1 p24 levels in infected primary
CD4+ T cells
We then asked whether Nef affects the levels of Gag pro-
teins in primary CD4+T cells. We infected PHA-activated
primary CD4+ T cells with VSV-G-pseudotyped WT or
ΔNef. As expected [46], VSV-G-pseudotyping rescued the
infectivity of HIV-1Δnef, such that at 24h post-infection
(p.i.) there was a similar percentage of Gag (KC57) positive
cells with WTand ΔNef (Figure 2a). However, at later time
points (days 2 and 3 p.i.), when secondary rounds ofFigure 2 Nef increases Gag proteins levels in infected primary CD4+
VSV-G-pseudotyped WT or ΔNef (50–150 ng of p24/ml) for 3 h. The virus w
Productive infection was followed by flow cytometry of intracellular HIV-1 G
of the fraction of Gag (KC57) positive cells at the indicated days post infect
MFI of intracellular Gag (KC57) staining calculated on the fraction of Gag (K
in cells described in Figure 1a are indicated. (c) Representative dot-plot ana
or ΔNef (at day 2 post-infection). Cells were exposed to a higher viral input
The percentage of Gag (KC57) positive cells is indicated in the top right co
infected cells from 11 independent infections (8 donors), selected for the s
panel). The MFI of Gag (KC57) is reduced in absence of Nef (right panel). Eareplication occurred and VSV-G-pseudotyping was lost,
ΔNef spread less efficiently than WT (Figure 2a). At days
2 and 3, the MFI of ΔNef-infected cells was significantly
reduced (Figure 2b). To rule out that these differences
may be due to a reduced number of ΔNef infected cells,
we used higher ΔNef-VSV-G inoculum, in order to get the
same fraction of infected cells at day 2 with WT and ΔNef
viruses. As shown in Figure 2c and 2d, when the propor-
tion of Gag (KC57) positive cells was equivalent with both
viruses, there was a significant reduction in the MFI of
KC57 staining in the absence of Nef.
We performed a western blot analysis of cell lysates of
primary CD4+ T cells infected with WT or ΔNef viruses to
assess the levels of p55 and p24. As shown with three inde-
pendent donors (Additional file 2), there were no major
differences in the amounts of p55 in WT and ΔNef
infected cells. However p24 was reduced by 25-50%, de-
pending on the donor, in the absence of Nef. Therefore, inT cells. PHA-activated primary CD4+ T cells were exposed to
as washed off and the infected cells were cultured for up to 3 days.
ag using the KC57 anti-HIV-1 p24 monoclonal antibody. (a) Evolution
ion. Data are Mean±SEM of cells from three independent donors. (b)
C57) positive cells. Maximum, Minimum and Mean of results obtained
lysis of Gag (KC57) staining of primary CD4+T cells infected with WT
of ΔNef than WT, in order to obtain similar fraction of infected cells.
rner of the gated population. MFI is also indicated. (d) Analysis of
ame fraction of Gag(KC57) positive cells at day 2 post-infection (left
ch infection has been symbol-coded. *p<0.05 (Mann Whitney test)
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ing of p55 into p24 is reduced in the absence of Nef.
Nef enhances viral cell-to-cell transfer in primary
CD4+ T cells
We previously showed that viral replication in primary lym-
phocytes in vitro occurs mostly through cell-to-cell con-
tacts, with very little contribution from free viral particles
[27]. We investigated how WT and ΔNef spread through
cellular contacts. We infected primary CD4+ T cells for
two days with VSV-G-pseudotyped WT or ΔNef, in order
to achieve the same amount of infected cells. We then used
these cells as donors to transfer the infection to autologous
activated CD4+ T cells. Donors were co-cultivated for two
hours with target cells stained with a fluorescent dye
(carboxyfluorescein succinimidyl ester or CFSE). The levels
of Gag proteins were then measured by flow cytometryFigure 3 Nef enhances viral cell-to-cell transfer in primary CD4+ T cel
ΔNef in order to get similar levels of Gag (KC57) positive cells, or, as a nega
with target lymphocytes pre-stained with carboxyfluorescein succinimidyl e
analysis of donors (upper panels) and targets (lower panels) in one represe
indicated in the top right corner of the gated population. MFI is also indica
in 5 independent experiments. (c) Contacts and virological synapses betwe
visualized by immunofluorescence. Donor cells were co-cultivated with CFS
(red) using a polyclonal rabbit anti-Gag antiserum. A contact was defined a
synapse was defined as a cell conjugate in which a polarization of Gag pro
Quantification of the percentage of conjugates (d) and virological synapse
Whitney test).with the KC57 antibody. One representative staining is
shown in Figure 3a and the summary of five independent
experiments in Figure 3b. Following 2 h of co-culture with
WT-infected donor cells, we observed transfer of viral ma-
terial (KC57 positive) in 3-7% of the targets. This percent-
age was significantly reduced when donors were infected
with ΔNef viruses. (Figure 3a and 3b).
The decreased viral transfer in the absence of Nef could
be due to a reduced number of VS formed between donors
and targets. We asked whether Nef might facilitate VS for-
mation. We examined how WT and ΔNef-infected primary
CD4+ lymphocytes formed conjugates with uninfected au-
tologous cells. Targets were stained with CFSE before being
incubated with donors for 1h. Using a rabbit polyclonal
anti-Gag antibody, we examined the localization of Gag
proteins in cell-cell conjugates by immunofluorescence and
confocal microscopy (Figure 3c). We scored approximatelyls. Primary CD4+ T cells were infected with VSV-G-pseudotyped WT- or
tive control, left uninfected (NI). These cells were then co-cultivated
ster (CFSE) for 2h, and analyzed by flow cytometry. (a) Dot plot
ntative experiment. The percentage of Gag (KC57) positive cells is
ted. (b) Percentages of Gag (KC57) positive primary CD4+ target cells
en infected donors (D) and uninfected CD4+ lymphocytes targets (T),
E-labeled (green) target cells for 1h and stained for HIV-1 Gag proteins
s a tight interaction between the cells (upper panel). A virological
teins was visible at the contact zone (lower panel). (c, d, e).
s (e) formed between donor and target cells. *p<0.05 (Mann
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of donor cells forming conjugates with targets was similar
(25% of the cells) with WT and ΔNef (Figure 3d). Approxi-
mately half of these conjugates displayed a polarization of
Gag proteins at the junction zone, corresponding to the
VS, without significant differences between WT and ΔNef
(Figure 3e). Thus, in line with a previous report [47], Nef
does not augment the capacity of infected cells to form
conjugates or to polarize Gag proteins at the VS. This sug-
gests that Nef affects the amount and/or the quality of the
transferred viral material from donors to targets at a step
that follows the formation of the VS.
Nef increases viral cell-to-cell transfer in HeLa-Jurkat
co-cultures
The absence of Nef affects viral transfer in primary CD4+
lymphocytes (Figure 3a and 3b). To gain further insights
into this process, we used HeLa cells as donors and Jurkat
T cells as targets. There are two main advantages of using
HeLa cells as donors. The first is that viral infection does
not spread beyond the first round of replication because
of the absence of the CD4 receptor. The second is that
targets can be easily separated at the end of the co-culture
period to analyze the transferred viral material. We previ-
ously reported that this experimental system allows the
analysis of cell-to-cell viral transfer and productive infec-
tion with similar results as those obtained in primary cells
[43,48]. HeLa cell were infected with VSV-G-pseudotyped
WT or ΔNef for 48 h and then co-cultivated with Jurkat T
cells for 2 h. Targets were harvested and half of the Jurkat
population immediately fixed and stained to analyze viralFigure 4 Nef increases viral transfer from HeLa to Jurkat cells. (a) HeL
having similar levels of Gag (KC57) positive cells by flow cytometry were co
harvested, and the percentage of Gag (KC57) positive cells was measured b
performed either in static conditions, to allow cell-to-cell contacts, in the p
productive transmission, or under gentle shaking to limit cell-to-cell contac
(mean + SEM), at 2 h and 24 h, is depicted. (b). Effect of Nef proteins from
transfected with HIV-1 ΔNef and with plasmids expressing Nef from HIV-1 (
with Jurkat target cells, which were harvested after 2 h. The percentage of
for WT. One representative experiment out of 2 is presented. *p<0.05; **p<transfer by flow cytometry using the KC57 antibody. The
remaining targets were maintained in culture up to 24 h
to analyze productive transmission. Figure 4a represents
the mean + SEM of at least four experiments. With the
WT virus, around 5% of the targets were Gag (KC57) posi-
tive at the end of the 2h-coculture, and this percentage fur-
ther increased to about 20% after 24 h. The Gag (KC57)
signal detected at 24 h mostly corresponded to newly syn-
thesized viral proteins, since it was significantly reduced
when the target cells were incubated with the reverse tran-
scriptase inhibitor nevirapine (NVP) (Figure 4a). In the ab-
sence of Nef, the fraction of positive cells was significantly
reduced to 2% after 2 h. The infection then progressed
slower than with the WT virus, reaching about 5% at 24 h.
We then verified that in this short-term co-culture sys-
tem, infected cells mostly acquired the infection through
direct contacts with donor cells, with a minimal contribu-
tion of free virions released in the medium. We previously
reported that maintaining infected lymphocytes under gen-
tle shaking prevents infection through cell-to-cell contacts
[27,48]. Shaking the HeLa-Jurkat co-culture significantly re-
duced the number of Gag (KC57) positive cells at 2 h
(Figure 4a), confirming that in this system cell contacts are
the major route of viral transfer. Interestingly, after 24 h,
8% of the targets maintained in gentle shaking during the
co-culture with WT-infected donor cells were Gag (KC57)
positive. This residual percentage may represent the contri-
bution of the few cell-cell contacts that could have occurred
under shaking, or low levels of infection achieved by cell-
free virions produced in the co-culture. Notably, ΔNef
transfer and spread were significantly reduced in shakena cells infected with VSV-G-pseudotyped WT- or ΔNef for two days and
-cultivated with target Jurkat cells for 2 h. Jurkat cells were then
y flow-cytometry at the indicated time points. Co-cultures were
resence of reverse transcriptase inhibitor nevirapine (NVP) to evaluate
ts. A compilation of at least 4 independent experiments per condition
different alleles on viral cell-to-cell transfer. HeLa cells were co-
LAI, NA7 and CFA-1), HIV-2 or SIVmac. Cells were then co-cultivated
Gag (KC57) positive Jurkat cells was measured at 2 h and set up at 1
0.01 (Mann Whitney test).
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of recognition of p55 and p24 by KC57, we used HeLa cells
transfected with WT and ΔPR HIV. In these cells, which
over-express viral proteins, KC57 recognized both viruses,
although the MFI of ΔPR transfected cells appeared 3–4
fold lower than WT (Additional file 3a). When these do-
nors were co-cultivated with Jurkat cells for 2 h, some viral
material was transferred. KC57 efficiently recognized the
WT viral material, but not the ΔPR (Additional file 3b).
However, ΔPR was transferred to Jurkat cells, as visualized
by Western blot (Additional file 3c). We conclude that
KC57 efficiently recognizes processed p24, and less effi-
ciently the p55 precursor.
We then asked whether expression of Nef in trans in
the donor cell rescues the ΔNef defect in transfer. Co-
transfection of Δnef proviral DNA with a Nef-encoding
plasmid (Nef-LAI) in HeLa cells enhanced ΔNef transmis-
sion to the levels achieved with WT (Figure 4b). Two
HIV-1 primary Nef alleles (from the NA7 and FA01 viral
strains) [49,50] as well as HIV-2 and SIVmac Nef proteins
enhanced ΔNef transmission (Figure 4b).
Altogether, these results show that Nef increases by 2
to 3-fold the transfer of viral material to targets at 2h in
the HeLa-Jurkat co-culture system. Consequently, the
presence of Nef significantly enhances productive viral
infection in target cells at 24h. Various Nef proteins
from primary HIV-1 strains, and from HIV-2 and SIV
isolates, enhanced viral cell-to-cell transfer, strongly
suggesting that this function is conserved among pri-
mate lentiviruses.
Nef increases HIV-1 p24 localization at the plasma
membrane of HeLa cells
Since Nef positively contributes to HIV-1 cell-to-cell
transfer, we further analyzed the effect of Nef on Gag
proteins in infected donor cells. We asked if Nef could
impact the intracellular localization of Gag proteins. We
infected HeLa cells with VSV-G-pseudotyped WT-GagGFP
or ΔNef-GagGFP virus and visualized the localization of
Gag-GFP proteins by confocal microscopy. The majority of
WT-GagGFP-infected cells showed a high GFP expression
(Figure 5a upper panels A-D), confirming the results
obtained by flow cytometry (Figure 1d). The Gag-GFP sig-
nal was distributed in the cytoplasm and at the plasma
membrane (Figure 5a, panels A-D). In the absence of Nef,
the Gag-GFP signal was lower (Figures 1d and 5a, lower
panels E-H), and observed mostly in the cytoplasm, with a
reduced localization at the plasma membrane.
These experiments suggest that Nef affects the intra-
cellular localization of Gag proteins in infected cells.
However, this analysis does not allow discrimination
between unprocessed and processed Gag, because the
GFP signal is associated with both forms of the viral
protein.To further document this process, we performed sub-
cellular fractionations and biochemical analysis of Gag-
expressing HeLa cells, in the presence or absence of
Nef. We used three different types of Gag-expressing
cells: cells expressing only the Gag precursor, cells ex-
pressing only the GagPol precursor, and HIV-1-infected
cells. To this end, we first co-transfected HeLa cells with
a CMV-based plasmid coding for either Gag (pGag) or
GagPol (pGagPol), along with a plasmid coding for HIV-1
Nef protein (pCMV-Nef) or a control plasmid (pCMV-
NefAS, in which the nef sequence was cloned in anti-
sense). Forty-eight hours following transfection, cell
lysates were prepared by dounce-homogenization and a
flotation assay was performed. This assay allows the separ-
ation of the different cell compartments in a 10-65-90%
sucrose gradient [17]. After ultracentrifugation, ten frac-
tions were collected, beginning with the least dense
(containing the membranes), and ending with the most
dense (corresponding to the cytoplasm). The proteins in
each fraction were then precipitated with tricloroacetic
acid (TCA), separated by SDS-page, and visualized by
western blotting using the 25A anti-HIV-1 p24 monoclo-
nal antibody. Representative western blots with Gag and
GagPol are shown in Figure 5b and 5c, respectively. The
fractions were also analyzed with an anti-caveolin-1 anti-
body. As expected, caveolin-1 was mostly localized in the
membrane fractions (Figure 5b and 5c). Nef was present
only in the cells transfected with the pCMV-Nef plasmid.
The relative densitometric intensities of p55 and p24
were quantified in three independent experiments
(Figure 5d). When the Gag precursor was expressed
alone, about 10% of p55 was localized in membranes.
This distribution was not modified by Nef (Figure 5d).
With the pGagPol plasmid, the main Gag species were p55
and p24 but other intermediary products were also visual-
ized. The GagPol precursor was barely detectable, most
likely because it was rapidly processed by the viral protease.
p55 was detected only in the cytoplasmic fraction, irre-
spective of the presence of Nef (Figure 5c and 5d). HIV-1
p24, instead, was distributed between the membranes and
the cytoplasm. In the absence of Nef, about 20% of the
protein was localized in membranes. Interestingly, this
percentage increased significantly (reaching approxi-
mately 35%) in the presence of Nef (Figure 5d). We then
performed similar experiments to track the distribution
of Gag proteins in HeLa cells infected with VSV-
G-pseudotyped WT or ΔNef viruses. As with GagPol-
transfected cells, the accumulation of HIV-1 p24 in the
membrane fractions was increased in the presence of
Nef (Additional file 4).
Altogether, these experiments show that Nef promotes
the accumulation of HIV-1 p24 in the membrane frac-
tion of HIV-1-infected or GagPol-expressing HeLa cells,
which may contribute to efficient cell-cell transfer.
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of infected primary CD4+T cells
We examined whether Nef also modifies localization of
Gag proteins in HIV-1-infected primary CD4+ lympho-
cytes. The cells were infected with VSV-G-pseudotypedFigure 5 (See legend on next page.)viruses and two days later, a flotation analysis was
performed on cell lysates. A representative experiment is
shown in Figure 6a, and the p55 and p24 distribution in
the different fractions are quantified in Figure 6b. Most
of the signal corresponded to p24, and to a lesser extent
(See figure on previous page.)
Figure 5 Nef increases HIV-1 p24 localization at the plasma membrane of HeLa cells. (a) HeLa cells were infected with VSV-G-pseudotyped
WT- or ΔNef-Gag-GFP viruses and plated on coverslips. 48 h after infection cells were fixed and analyzed by confocal microscopy. Representative
images for WT-GagGFP infected (A-D) and ΔNef-GagGFP (E-H) are shown. White arrows indicate Gag-GFP proteins localized at the plasma
membrane. Red arrows point to Gag-GFP proteins accumulating intracellulary. (b, c) HeLa cells were transfected with a plasmid coding for Gag
(pGag) or GagPol (pGagPol) together with a plasmid coding for HIV-1Lai Nef protein (pCMV-Nef) or a control plasmid in which the Nef sequence
was in antisense (pCMV-NefAS). 48 h after transfection, dounce-homogenized cells were subjected to membrane flotation analysis. Panels (b) and
(c) show representative western blots probed with an HIV-1 p24 monoclonal antibody (25A). Numbers on top of each lane indicate the loaded
fractions. Fractions 2–4 and 8–10 correspond to membranes and cytoplasm, respectively. The immature (p55) and mature (p24) forms of Gag/
GagPol are indicated. The blots were also probed with an anti-caveolin-1 antibody. (d) The percentages of the different Gag proteins in the
membrane fractions were calculated and the mean+SEM of 3 independent experiments is shown in **p<0.01 (Mann Whitney test).
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associated p24 was higher with WT than with ΔNef. This
result was confirmed by compiling the mean and SEM of
experiments performed on cells from four independent do-
nors (Figure 6c). With the WT virus, 35% of Gag and 50%
of p24 respectively, were localized in the membrane frac-
tions. These percentages were significantly reduced to 15
and 25%, respectively, in the absence of Nef.
Thus, in infected primary CD4+T cells, Nef promotes
the localization of p55 and p24 to the membrane fraction.ΔNef-infected donor cells mostly transfer immature viral
material to target cells
To further investigate the impact of Nef on viral transfer,
we infected HeLa cells with two different doses of VSV-
G-pseudotyped WT HIV-1 or HIV-1ΔNef and co-
cultivated them with targets for two hours. We then
performed a western blotting analysis of total Gag proteins
in donor and in target cells harvested after the co-culture.
A representative western blot is shown in Figure 7a with a
quantification of the intensities of the p55 and p24 bands
in Figure 7b. In Figure 7c, the mean and SEM of the ratio
between mature and immature Gag proteins (p24/p55)
are shown, as quantified in donor and target cell lysates
from three independent experiments.
In donor cells, both p55 and p24 expression increased
in an input dependent manner. WT-infected donor cells
showed a p24/p55 ratio around 1, meaning that at the
steady state, precursors and mature Gag proteins are
present at similar levels. ΔNef-infected donors had a
slightly lower p24/p55 ratio, associated with reduced
overall amount of p24.
We then characterized the nature of the viral material
acquired by Jurkat target cells during the 2h co-culture.
With WT virus, the viral material transferred was mostly
mature (p24/p55 ratio of 2.5, Figure 7c). The situation was
different with ΔNef-infected donors: the amount of trans-
ferred p24 was reduced (Figure 7a), in line with the results
obtained by flow cytometry (Figure 3), and the p24/p55
ratio was significantly reduced to 0.7 (Figure 7c).
Therefore, in the absence of Nef, there is not only a re-
duction in the amount of viral material being transferredto target cells, but also a qualitative defect in its matur-
ation state.Discussion
We report here that the steady-state levels of Gag proteins
in HIV-1-infected primary CD4+ lymphocytes and Hela
cells are increased in the presence of Nef. Using imaging
and biochemical approaches, we show that Nef changes
the total amount and localization of both immature and
mature forms of Gag proteins. In WT infected cells, Gag
proteins are highly expressed, partially distributed in the
cytoplasm and mostly localized at the plasma membrane.
In the absence of Nef, expression of Gag proteins is lower,
primarily cytoplasmic, and partially localized to the plasma
membrane. Furthermore, the amount of HIV-1 p24 present
in the supernatant of ΔNef-infected cells is lower than that
of cells infected with the WT virus (this work and [51]).
However, viral release, calculated as the ratio between the
extracellular levels and the total amount (released plus cell-
associated) of HIV-1 p24 is unaffected. The absence of Nef
in infected lymphocytes does not affect their capacity to
form virological synapses, confirming previous results [47].
Once the virological synapse is formed, WT-infected cells
transfer mostly mature viral particles to uninfected cells,
whereas in the absence of Nef, the amount of transferred
viral material is reduced and mostly immature. Together,
these results strongly suggest a previously unappreciated
effect of lentiviral Nef on the expression, intracellular
localization and processing of Gag proteins, providing
novel insights into how Nef optimizes viral replication.
How does Nef increase the amount of Gag proteins in
infected cells? One possibility is that Nef, by affecting the
HIV-1 long terminal repeat (LTR) activity, modulates Gag
and GagPol expression. However, discrepant results have
been reported regarding the effects of Nef on the transcrip-
tional activity of the LTR [52-59] . This hypothesis will de-
serve further investigation. Later in the viral life cycle, Nef
may prevent the degradation of Gag proteins or of other
proteins involved in the trafficking or assembly of Gag
and/or GagPol. In support of this, it has been reported that
proteasome inhibitors partly rescue the infectivity defect of
ΔNef viruses [60]. Interestingly, Nef also increases levels of
Figure 6 Nef induces HIV-1 p55 and p24 localization in membranes of infected primary CD4+T cells. (a) Primary CD4+T cells were
infected with VSV-G-pseudotyped WT or ΔNef. Two days post-infection cells were collected, dounce-homogenized and subjected to membrane
flotation analysis as in Figure 5. Representative western blots of WT- (left) or ΔNef-infected (right) primary CD4+T cells are shown. (b). Quantitative
densitometry analysis of the western blots for p55 and p24. The x-axis shows the pixel location in each fraction and y-axis indicates the pixel
intensity. (c). The percentages of p55 and p24 found in the membrane fractions was calculated and the mean+SEM of experiments performed
with cells from 4 independent donors is shown. *p<0.05 (Mann Whitney test).
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for Gag trafficking and stability in infected cells [62].
The molecular and cellular mechanisms underlying
the effects of Nef on the amount, trafficking and pro-
cessing of Gag proteins remains to be further character-
ized. We hypothesize that Nef might positively impact
the Gag biosynthetic pathway by acting at various levels.
In the cytoplasm, Gag is mostly monomeric or dimeric,
whereas higher ordered Gag multimers are found only
at the plasma membrane [17]. Gag assembly and viral
budding is a cooperative process that depends on the
amount of intracellular Gag [18]. Thus, the reduced
amount of Gag proteins observed in the absence of Nef
could lead to an inefficient localization at the plasma
membrane.
Nef is known to interact with the clathrin-dependent
endocytic pathway and to modulate the surface expres-
sion of various cellular proteins [63,64]. Gag contains a
dileucine-like sorting motif that regulates association
with multivesicular bodies [65]. Gag interacts directly
with the AP-3 complex, a component of the clathrin path-
way [66,67], and trafficking of Gag to late endosomes is
part of a productive particle assembly pathway prior tobudding from the plasma membrane [11,66]. It is thus
tempting to speculate that Nef may affect Gag trafficking
through its effect on the clathrin-mediated cell sorting ma-
chinery. Nef also modulates actin dynamics by inactivating
cofilin [68], while the microtubule network is dispensable
for proper targeting of Gag at the plasma membrane [11].
It will be worth determining whether the effects of Nef on
the actin cytoskeleton impact the overall levels of Gag pro-
teins in infected cells.
Further work is thus warranted to determine which of
these potential activities mediate the effects of Nef on Gag
proteins. For instance, it may be of interest to determine
which Nef mutants, known to be selectively defective in dif-
ferent activities of the viral protein, impact Gag localization
and processing. Additionally, it has been shown that mur-
ine leukemia virus (MLV) glycosylated gag (Glycogag) pro-
teins rescue the infectivity of Nef-defective virions [69]. It
will be worth examining whether Glycogag also impacts the
trafficking and processing of HIV-1 Gag.
We further report a possible consequence of the effects
of Nef on Gag proteins. Using two short-term co-culture
systems (co-culture of infected HeLa cells with Jurkat tar-
get cells, and co-culture of primary CD4+ T cells), we
Figure 7 ΔNef-infected donor cells mostly transfer immature viral material to target cells. (a) HeLa cells infected with two doses of
VSV-G-pseudotyped WT or ΔNef viruses were used as donors to transfer the infection to Jurkat target cells as described in Figure 4. After a
co-culture of 2 h, donors and targets were separately harvested and cell lysates were analyzed by western blotting with a monoclonal
anti-HIV-1 p24 antibody (25A). A representative experiment is shown. (b) Quantitative densitometry analysis of the western blots for p55
and p24. The x-axis shows the pixel location in each fraction and y-axis indicates the pixel intensity. (c) The ratio between mature (p24) and
immature (p55) forms of Gag proteins in HeLa donors and Jurkat target cells was calculated and the mean+SEM of 3 independent
experiments is shown. *p<0.05 (Mann Whitney test).
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terial transferred is different in the presence or in the ab-
sence of Nef. Without Nef, the percentage of targets
having received viral material is significantly reduced.
Moreover, by western blot analysis, we demonstrate that
the p24/p55 ratio on targets, reflecting the amount of ma-
ture viral material passing from donor to target cells is
also significantly reduced in the absence of Nef. In donor
cells, without Nef, we observed a slight reduction of the
p24/ p55 ratio as compared to cells infected with WT
virus. This raises questions about how and which viral ma-
terial is actually transferred from donors to targets. Recent
fluorescence microscopy methods demonstrated that viral
assembly, budding and release in the supernatant are rapid
processes [70,71]. It will be interesting to understand
whether the dynamics of HIV-1 assembly are similar in
the presence or in the absence of virological synapses
[72,73] and if Nef plays a role in Gag assembly. Hubner
and colleagues [63] showed that Gag proteins moving
across the synapse toward the target cells originate from
regions of the donor cells close to the cell-contact site.
Thus, in the absence of Nef, the decreased quantity of viral
material transferred to targets could be a direct conse-
quence of the reduced amount of Gag proteins at the
plasma membrane of donor cells. Moreover, Nef modulatesthe lipid content and the nature of the cellular proteins
present at the cell membrane, a process that may enhance
viral infectivity [74,75]. Since rafts and other membrane
microdomains polarize at the site of viral transfer and are
considered as privileged Gag assembly sites [9,76], a modu-
lation of the composition of the cellular membranes could
affect Gag/GagPol assembly and subsequent processing. At
the membrane, virions bud mostly as immature particles.
Maturation starts during the late phases of or immediately
after budding, when the autocatalytic cleavage of the PR
activates this enzyme to produce the mature viral core
[77]. Nef directly binds the GagPol-p6* transframe protein,
but not Gag-p6, and redirecting Nef to the endoplasmic
reticulum inhibits the activity of Nef on Gag processing
and virion production [78]. Gag processing occurs during
Gag/GagPol assembly at the plasma membrane, but not
during membrane trafficking [79] and the ratio between
Gag and GagPol significantly impacts the intracellular dis-
tributions of mature Gag and the infectivity of the viral
particles produced [79]. Thus Nef binding to p6* may
modulate the trafficking of the viral structural proteins and
affect their processing.
The increase of HIV-1 p24 in membrane fractions in-
duced by Nef is visible in HIV-1 infected cells (HeLa or
primary CD4+ lymphocytes), as well as in HeLa cells
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promote p55 accumulation at the membrane when this
viral protein is expressed alone. This suggests that the in-
crease of p55 and p24 at the plasma membrane observed
in infected cells might depend on the interaction of Nef
with the GagPol proteins synthesized during viral replica-
tion. Of note, a part of the p24 signal detected in the
membranes fraction could also result from virus being re-
leased and re-internalized [9,11,71,80]
At later time points, this altered transfer of viral ma-
terial is associated with a reduction of productive infec-
tion of target cells. This is demonstrated here after 24 h
of viral replication in Jurkat cells that have been sepa-
rated after 2 h of contact with Hela donor cells. Of note,
a positive effect of Nef on viral replication was observed
in primary CD4+ T cells when the sources of infection
were either cell-free viruses (Figure 1a) or infected lym-
phocytes co-cultivated with autologous targets (not
shown). The effect of Nef on Gag proteins amount and
trafficking described help explain the slower kinetics of
replication observed for ΔNef viruses. Portillo and col-
leagues [32] showed that cell-to-cell transmission signifi-
cantly increases the number of copies of viral DNA
integrated in the host genome. The differences in the
quantity and quality of transferred viral material between
WT and ΔNef could thus affect the number of integra-
tion events and the amount of viral proteins produced
per infected cells. Moreover, there are less mature vi-
rions transferred in the absence of Nef, so the fusion
events at the virological synapse could also be affected
[81]. Additionally, we show that in the absence of Nef,
the amount of transferred immature viral material is sig-
nificantly increased. It has been recently proposed [40]
that immature viral particles are first endocytosed and
then undergo maturation inside the target cell. Without
Nef, this “excess” of immature viral material may neces-
sitate a longer maturation time, which may further delay
viral replication.
The profile of maturation of Gag proteins in extracel-
lular virions is considered to be similar with or without
Nef ([82], and not shown). However, these analyses were
generally performed on viral particles harvested after
long periods of times (i.e. after a few hours to a few
days). This may have masked short-term effects of Nef
on the kinetics of viral maturation after extracellular
release.
Conclusion
Nef accelerates viral spread through partly characterized
mechanisms. Our work describes a new role of Nef in
modulating various steps of the viral Gag pathway. We
demonstrate that in the presence of Nef, Gag proteins
are localized more efficiently at the plasma membrane,
where new virions are built. We further show that theprocessing of Gag into mature products is enhanced and
that cell-to-cell viral transfer is more efficient. It is
tempting to speculate that the activity of Nef described
here is relevant to viral spread and pathogenesis in vivo.
Nef proteins from HIV-1 primary isolates, HIV-2 and
SIV strains, enhance viral cell-to-cell transfer, indicating
that this function is conserved among primate lentivi-
ruses. Infected cells are vehicles for viral spread in vivo
[25]. In HIV-positive individuals, productively infected
CD4+ T cells have a short half-life (1.6 days) [83], and
consequently a short time to spread the infection. The
facilitation of proper Gag proteins trafficking and pro-
cessing and cell-to-cell transfer likely represent critical
aspects of Nef function, which may help explain why
viral loads are significantly reduced in infected individ-
uals harboring Nef-defective viruses.
Methods
Cells
Jurkat (clone 20), HeLa and 293T cells were grown as
described [28]. Primary CD4+ T cells were purified from
human peripheral blood by density gradient centrifuga-
tion (Lymphocytes separation medium, PAA) followed
by positive immunomagnetic selection (Miltenyi). About
98% of cells were CD4+CD3+. For activation, primary T
cells were treated with phytohemagglutinin (PHA, 1 μg/
ml) (Remel, Dartford, UK) for 24h at 37°C and then cul-
tured in interleukin 2 (IL-2)-containing medium (50 IU/
ml) for one week before being used.
Virus, Infections and Transfections
Virus stocks were prepared by transfection of 293T cells
([28]). For some experiments viral supernatants were
ultracentrifuged at 22000 rpm for 2h at 4°C through a 20%
sucrose cushion. Cells were infected with the X4 HIV-1
strains NL4-3 (WT), NL4-3ΔNef (ΔNef), NL4-3-GFP
(WT-GFP) or NL4-3ΔNef-GFP, pseudotyped with the ves-
icular stomatitis virus G protein (VSV-G) to allow more ef-
ficient viral entry. For Nef complementation experiments,
HeLa cells were co-transfected with pNL4-3Δnef along with
plasmids expressing HIV-1 Nef LAI, NA7 and FA01 pri-
mary alleles, HIV-2 or SIV Nef [49,50]. Co-transfections of
Nef and Gag or GagPol plasmids were performed at a ratio
of 2:1, respectively. For transfections, Lipofectamine2000
(Invitrogen) or Metafectene (Biontex Laboratories) was
used following manufacturer’s instructions. Transfected
cells were then co-cultivated with target Jurkat cells or used
in flotation assay as described below.
Anti Gag proteins antibodies
Anti-HIV-1 p24 monoclonal antibody KC57 (clone
FH190-1-1; Coulter); anti-HIV-1 p24 monoclonal anti-
body produced by the hybridoma cell line 183-H12-5C
(NIH AIDS Reagent Program, Division of AIDS, NIAID,
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Institut Pasteur).
Flow cytometry
To measure HIV-1 Gag proteins expression, infected cells
were permeabilized in PBS/1% BSA/0.01% Sodium Azide/
0.5% Saponin (Sigma) and stained using different anti
HIV-1 p24 antibodies: anti-HIV-1 p24 phycoerythrin mAb
KC57 was diluted 1:500; anti-HIV-1 p24 monoclonal anti-
body 183-H12-5C was diluted 1:1000. Secondary antibody
anti-mouse Alexa-647 (Invitrogen) was used to detect
183-H12-5C primary antibody. Isotype-matched mAbs
were used as negative controls. Samples were analyzed
with either a FACSCalibur instrument (Becton Dickinson)
and CellQuest software or a BD FACSCanto II (BD Biosci-
ences) and Diva software.
Analysis of HIV-1 cell-to-cell transfer
HIV-1 cell-to-cell transmission assay has been previously de-
scribed [27,48]. Briefly, 48 h after transfection or infection,
equivalently (±5% accordingly to flow cytometry staining
with KC57 anti-HIV-1 p24 antibody) infected HeLa donor
cells were co-cultivated with target T cells labelled with
Carboxyfluorescein succinimidyl ester (CFSE-Invitrogen).
Staining of target cells with CFSE (final concentration 500
nM) was performed in RPMI without fetal bovine serum
(FBS) for 5 minutes at 37°C. Cells were then washed once in
RPMI without FBS, resuspended in complete media and co-
cultivated with donors for 2 h. Targets were then harvested,
washed, and incubated at 37°C up to 24 h. At the indicated
time points, cells were stained using the anti-HIV-1 p24
KC57 antibody and analyzed by flow cytometry. When
stated, the reverse-transcriptase inhibitor nevirapine (NVP,
at 25 nM) was added during the co-culture and maintained
during the assay. Co-cultures of primary CD4+ T cells were
performed similarly, except that donor and target cells were
kept together for 2 h.
Immunofluorescence
Analysis of conjugates and virological synapses has been
previously described [28]. Briefly, HIV-1-infected donor
cells were mixed with targets pre-labelled with CFSE (200
nM, Invitrogen) at a 1/1 ratio and loaded on polylysine-
coated coverslips. After 1 h at 37°C, cells were fixed 10
min with 4% PFA. Cells were stained with a rabbit poly-
clonal anti-Gag proteins (a kind gift of Pierre Boulanger)
[84] and analyzed by confocal microscopy on a Zeiss
LSM700 microscope. HeLa cells were plated on glass cov-
erslips and the day after transfected with proviral DNA
coding for the pNL4-3 or the nef-deleted counterpart ex-
pressing the green fluorescent protein (GFP) in frame with
the HIV p17 protein [45]. Two days after transfection,
cells were fixed and analyzed by confocal microscopy on a
Zeiss LSM-700 microscope.Membrane flotation assay (equilibrium flotation
centrifugation)
The membrane flotation assay was performed as previ-
ously described [17]. In brief, approximately 1×107 cells
were washed three times with NTE buffer (100 mM
NaCl, 10 mM Tris [pH 7.4], 1 mM EDTA) and
resuspended in 500 μl of hypotonic buffer (10 mM Tris
[pH 7.4], 1 mM EDTA) supplemented with protease in-
hibitors. Samples were lysed by dounce homogenization
and adjusted to 150 mM NaCl and 1 mM MgCl2. Nu-
clei and intact cells were removed by centrifugation for
10 minutes at 1000× g, 4°C. Thereafter, 350 μl of super-
natant was mixed with 1650 μl of 90% sucrose solution
(prepared in 150 mM NaCl, 10 mM Tris [pH 7.4], 1
mM EDTA, 1 mM MgCl2) and overlayed with 6.5 ml of
65% and 2.5 ml of 10% sucrose solutions prepared simi-
larly and supplemented with protease inhibitors. Cen-
trifugation was performed in a Beckman SW41 Ti rotor
at 35,000 rpm for 18 h. Ten fractions (1 ml each) were
collected from the top of the gradient and used for pro-
tein analyses by western blotting using the monoclonal
anti-HIV-1 p24 antibody 25A.Enzyme-linked immunosorbent assay (ELISA)
Viral production was monitored by measuring HIV-1 anti-
gen p24 in supernatants and cell-associated by ELISA.
Plates were coated using a monoclonal antibody anti-HIV-1
p24 183-H12-5C diluted 1:10000 and revealed using an anti
HIV-1 polyclonal serum.Western blotting
Cells were lysed in PBS-1% Triton X-100 (Sigma-Aldrich)
supplemented with protease inhibitors (Complete; Roche).
Cell lysates were analyzed by SDS-gel electrophoresis using
4–12% Bis-Tris Criterion gels (BioRad) or 3-8% Tris-
Acetate gels (Invitrogen). The following antibodies were
used: mouse monoclonal anti-HIV-1 p24 clone 25A, mouse
anti-Nef MATG020 (Transgene) or a rabbit HIV-1 Nef
Antiserum (NIH AIDS Reagent Program, Division of AIDS,
NIAID, NIH: Catalog #2949, from Dr. Ronald Swanstrom);
rabbit polyclonal anti-caveolin-1 antibody (clone N-20,
Santa Cruz Biotechnology); mouse monoclonal anti beta-
actin (clone AC-15, Sigma Aldrich). HRP- or IRDye-
coupled specie-specific secondary antibodies were used.
Western Blot HRP quantification was performed using
ImageJ software from NIH; fluorescent signals were
detected and quantified using Image Studio (LICOR
Odyssey).Statistical analysis
Statistical analyses (Mann-Witthney unpaired t test) were
performed using GraphPad Prism software.
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Additional file 1: Analysis of the recognition of Gag proteins by
flow cytometry and western blot using various anti HIV-1 p24
antibodies. (a) VSV-G-pseudotyped WT- or ΔNef-infected HeLa cells were
stained with the anti HIV-1 p24 KC57 antibody 48h after infection. The
percentage of KC57 positive cells and relative MFI are indicated in the top
right corner of the gated population and in the low right corner of the dot
plot, respectively. (b) Lysates of infected cells loaded on a SDS-page
polyacrilamide gel and blotted with a monoclonal anti-HIV-1 p24 antibody
(25A) to visualize all Gag proteins. A representative western blot is shown
corresponding to the dot plots shown on the left. NI: not infected (c) Mean
+SEM of the p55 and p24-associated fluorescence in 3 independent
experiments. (d) 48 h after infection HeLa cells were stained with the anti
HIV-1 p24 183 antibody. The percentage of 183 positive cells and the
relative MFI are indicated. (e) Mean ± SEM of the Gag (183) MFI in 5
independent infections. (f-g): The 183 antibody preferentially recognize the
mature HIV-1 p24. (f) HeLa cells were transfected with WT or ΔPR proviral
DNA or left not transfected (NT). The amount of released HIV-1 p24 antigen
was measured by ELISA 48 h after transfection. The 183 antibody was used
to coat the ELISA plates. Amount of HIV-1 p24 antigen measured before
(gray bar) and after (white bar) ultracentrifugation of the supernatants on a
sucrose gradient. (g) The ultracentrifuged particles were analyzed by
western blotting using the 25A antibody. 1 ng of antigen p24 was loaded
for the WT virus. For the ΔPR virus, undetectable by ELISA, was loaded the
same volume of ultracentrifuged virus loaded for the WT. One
representative experiment out of 2 is shown **p<0.01 (Mann Whitney test)
Additional file 2: The amount of processed HIV-1 p24 is reduced in
cell lysates of primary CD4+T cells infected with ΔNef viruses.
Primary CD4+T cells derived from PBMCs of healthy donors were sorted by
immunomagnetic selection, activated with PHA and maintained in culture
with IL-2 for one week before being infected with VSV-G-pseudotyped WT
or ΔNef viruses. At day 2 post infection, cells were harvested and part of
them fixed, permeabilized and stained with the KC57 antibody. Cells were
then analyzed also by western blotting using the 25A antibody as described
in the additional file 1 and in the materials and methods. Quantification of
the p55 and p24 bands was performed for each donor using the Odyssey-
LICOR system. As shown in three independent donors, in absence of Nef
the fluorescence associated with the p24 band was reduced by 25-50%,
depending on the donor, whereas no major differences were observed in
the amount of p55.
Additional file 3: The monoclonal antibody anti HIV-1 p24 KC57
preferentially recognizes mature p24 by flow cytometry. HeLa cells
were transfected with proviral DNA coding for WT, or ΔPR, which is
defective for the viral protease. 48 h after transfection, HeLa cells were
used as donors for a 2 h co-culture with Jurkat target cells. (a) Donors
were analyzed by flow cytometry using the anti HIV-1 p24 monoclonal
antibody KC57. This antibody recognizes both the Gag precursor and
mature proteins in donor cells, which over-express the viral proteins.
Note that the MFI of the ΔPR provirus is reduced. (b) Targets were
analyzed by flow cytometry using the anti HIV-1 p24 KC57 antibody. In
target cells the Gag (KC57) signal is visible with the WT virus, and barely
detected with ΔPR. (c) Donor and target cells were also harvested
separately and analyzed by western blotting using the anti-p24
monoclonal antibody 25A. In donor cells, Gag species from both WT and
ΔPR were detected. As expected, ΔPR produced only the Gag precursor
(p55). A similar profile of staining was obtained in target Jurkat cells. Of
note, KC57, when used in the western blot experiment, also detects both
p55 and p24 (not shown). One out of two experiments is shown.
Additional file 4: Nef induces HIV-1 p24 localization in membranes
of infected HeLa cells. (a) HeLa cells were infected with VSV-
G-pseudotyped WT or ΔNef. Two days post-infection, cells were collected,
dounce-homogenized and subjected to membrane flotation analysis, as
described in Figure 5. The panels show representative western blots
probed with the HIV-1 p24-specific monoclonal antibody 25A. Numbers
on top of each lane indicate the loaded fractions. Fractions 2–4 and 8–10
correspond to membranes and cytoplasm, respectively. The immature
(p55) and mature (p24) forms of Gag and GagPol proteins are indicated.
(b) Quantitative densitometry analysis of the western blots for p55 andp24. The x-axis shows the pixel location in each fraction and y-axis
indicates the pixel intensity. (c) The percentages of p55 and p24 found in
the membrane fractions were calculated and the mean+SEM of 3
independent experiments is shown.
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